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Background and Objectives 
Although telehealth research among the general population is voluminous, study quality is low and 
results are mixed. Little is known specifically concerning older people and their self-efficacy to engage 
with and benefit from such technologies. This paper reviews the evidence for which self-care telehealth 
technology supports the self-efficacy of older people with long-term conditions (LTCs) living at home.  
Research Design and Methods  
Following PRISMA guidelines, this overview of systematic reviews focused on four LTCs and the concept 
of ‘self-efficacy’. Quality was appraised using R-AMSTAR and study evaluation was guided by the PRISMS 
taxonomy for reporting of self-management support. Heterogeneous data evidencing technology-
enhanced self-efficacy were narratively synthesised. 
Results  
Five included papers contained 74 primary studies involving 9,004 participants with chronic obstructive 
pulmonary disease (COPD), hypertension, heart failure or dementia. Evidence for self-care telehealth 
technology supporting self-efficacy of older people with LTCs living at home was limited. Self-efficacy 
was rarely an outcome, also attrition and drop-out rates and mediators of support or education. The 
pathway from telehealth to self-efficacy depended on telehealth modes and techniques promoting 
healthy lifestyles. Increased self-care and self-monitoring empowered self-efficacy, patient-activation or 
mastery. 
Discussion and Implications 
Future research needs to focus on the process by which the intervention works and the effects of 
mediating variables and mechanisms through which self-management is achieved. Self-efficacy, patient-
activation, and motivation are critical components to telehealth’s adoption by the patient, and hence to 
the success of self-care in self-management of LTCs. Their invisibility as outcomes is a limitation. 
 





Despite the progress in diagnosis and treatment of chronic LTCs, the prevalence in LTCs such as COPD, 
heart failure, hypertension and dementia continues to rise (George & Martin, 2016). Pressures on health 
and social care systems are increasing as a result, with wait times in the UK for routine and emergency 
care the highest in a decade, including accident and emergency services, further driving up demand for 
hospital beds (KingsFund.org.uk, 2018). Meanwhile, healthcare costs are also rising as UK local 
authorities face budget reductions (LGA, 2018) and half of National Health Service (NHS) providers 
forecast a financial deficit (KingsFund.org.uk, 2018). Such trends disproportionately affect older people, 
especially those with multiple LTCs and from lower socio-economic backgrounds (Allen & Daly, 2016; 
KingsFund.org.uk, 2019). Governments, particularly in high-income countries are seeking technological 
‘solutions’ to address the rising patient numbers and costs associated with LTCs (Hanlon et al., 2017; 
Parati, Pellegrini, & Torlasco, 2019). In order to reduce the pressure on healthcare services, particularly 
in relation to older people, the use of telemedicine, telemonitoring, telehealth and other technological 
configurations, applications, devices and platforms is becoming more prevalent for patient-provider 
communication to support self-management.  
This overview was stimulated by our work in the area of health technologies for LTCs as part of the 
Lancashire and Cumbria Innovation Alliance (LCIA) Testbed (Varey et al., 2018). An initial survey of the 
evidence-base for healthcare technology and older people with LTCs revealed two points. Firstly, the 
plethora of work that has emerged in recent years around healthcare technology has given rise to a 
somewhat confusing set of terms used to describe it. Terminology tended to complicate rather than 
clarify the topic. To address this, Murphy, Harrington, Taylor, Teljeur, Smith, Pinnock, & Ryan (2017) 
suggested using the single term ‘telehealth’ to encompass all ‘health-based IT-based care’ and the term 
‘self-management’ as ‘the provision of interventions to increase patients’ skills and confidence, 
empowering the individual to take an active part in their disease management’ (p. 276). Their goals of 
self-management include optimizing and preserving physical health; reducing symptoms and functional 
impairments in daily life, increasing emotional and social-well-being, establishing effective alliances with 
healthcare professionals as well as friends, family and others in the community, as well as improving 
overall quality of life.  
Secondly, it became clear that whilst there is voluminous published evidence on different forms of 
telehealth, we sought evidence for which telehealth might support self-efficacy and self-management 
amongst older people. This is important given government and health policy is placing increasing 
emphasis on enhancing self-efficacy and the self-management of care, not just to facilitate older 
people’s ability to remain at home for longer but also to reduce hospital admissions and GP visits. 
Furthermore, many LTCs affect a broad age range of people (diabetes and asthma studies focused on 
participants >18 years). Technology adoption (Mitzner et al., 2019) and task performance by older adults 
(Schmidt & Wahl, 2019) are receiving much-needed attention in individual studies. Given there were 
already a number of papers reviewing telehealth, we chose to undertake a review of reviews (an 
overview) in order to bring together knowledge and insights already synthesised within these published 
papers rather than undertaking yet another review of single studies. Therefore, we chose to provide an 
overview of evidence on telehealth, older people and self-efficacy. Hence, this study focuses on our 
objective stated below and the four specific LTCs most prevalent among our Testbed participants.  
Objective  
Our primary objective for undertaking this overview of systematic reviews is to understand what the 
existing evidence base is for how health technology can support self-efficacy of older people with 
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specific LTCs. Hence, we aimed to collect, appraise and synthesize existing evidence from multiple 
systematic reviews on the extent to which self-care telehealth technology supports self-efficacy of older 
people with LTCs (specifically hypertension, COPD, heart failure and dementia) living at home.  
 
DESIGN and METHODS 
We undertook a thorough search of the literature, adhering to methodological guidance for quality 
reviews (CRD, 2009; Heyn, Meeks, & Pruchno, 2019) and formulated the scope of the research using 
PICOS. A scoping of the literature was first performed to identify key papers, refine inclusion/exclusion 
criteria, identify keywords and develop a search strategy. Based on the quantity of existing literature we 
decided to conduct an ‘overview of systematic reviews’, including only papers that comprised systematic 
reviews or meta-analyses. Use of a theoretical framework is recommended for guiding the development 
and implementation of health interventions (Craig, Dieppe, Macintyre, Michie, Nazareth, & Petticrew, 
2013). Since self-efficacy is a feasible framework to guide intervention development for chronic health 
conditions (Tougas, Hayden, McGrath, Huget, & Rozario, 2015) we focused on this concept as well as 
associated terms such as motivation, patient-activation, mastery and empowerment are also used in 
describing a person’s resiliency towards adversity and perseverance against obstacles. We therefore 
sought these as outcome measures. (Further details of Design and Methods can be found in Table 1.) 
The LICA Testbed implemented innovative combinatorial technologies and practices. Objectives were to 
use a combination of health technologies and services to better support frail older people living with a 
range of LTCs, to improve patient activation (NHS, 2019) and their ability to self-care at home. Because 
we reviewed literature with complex interventions in mind, we felt that the PRISMS taxonomy provided 
a useful framework for identifying the quality of reporting. The Practical Reviews in Self-Management 
Support (PRISMS) study responded to the poor standard of reporting of complex interventions, 
specifically those for self-management support by developing a useful descriptive taxonomy (Pearce, 
Parke, Pinnock, Epiphaniou, Bourne, Sheikh, & Taylor, 2016; Taylor et al., 2014). PRISMS’ dimensions 
(Mode of delivery; Personnel delivering support; Targeting; and Intensity, frequency and duration of the 
intervention) were incorporated into Table 2. Characteristics. 
Selection criteria 
Eligible studies met the following inclusion criteria: 
 Participants - Older adults 50 years and older with LTCs (heart failure, COPD, hypertension or 
dementia), living at home. Reviews of chronic diseases in general (rather than just one of the 
specified four listed above) are included if >50% of the studies have subgroup analysis relevant 
to the 4 included LTCs. (See Table 1) 
 Interventions – Telehealth technology or device interventions to support or improve self-
management / self-care at home 
 Comparators - Usual care or alternative means of delivering the intervention (e.g., face-to-face, 
paper-based). A comparator was not essential for inclusion. 
 Outcomes - Self-efficacy, patient-activation, mastery, components of supported self-
management 
 Study design - Systematic reviews of any study design. No date limits. English only.  
Ineligible studies included:  
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 Tracking or passive monitoring (patient not involved in measuring and communicating data with 
practitioner), implantable devices, surveillance, smart homes, home health care by an agency, 
physical activity promotion, robotics, AI or virtual reality. 
Search strategy and process 
Keywords with the combination of AND, OR and NOT and medical subject heading terms were used for 
searching the concepts of chronic disease, technology, self-efficacy and systematic review. The search 
strategy and terms were peer-reviewed by subject experts on the Testbed project and refined in team 
meetings (See Supplemental file 1. Search strategy). Ten electronic databases were searched. Manual 
searching of journals, reference lists of all eligible reviews searched, and backwards and forwards 
citation searching was performed for all included systematic reviews.  
Publications were selected and reporting guided by The Preferred Reporting Items for Systematic 
Reviews and Meta-Analyses Statement (PRISMA) flow diagram (Liberati et al., 2009; Moher, Liberati, 
Tetzlaff, Altman, & Prisma Group, 2009) and checklist (Supplemental file #3). The first author screened 
all titles and abstracts for relevance. It was necessary in about 5% of cases to review the full text 
publication as the abstract was incomplete or unclear. After removal of duplicates and screening of titles 
and abstracts, 22 publications from 6,719 citations were identified by the lead author for possible 
inclusion. To cross-check the accuracy of the title and abstract screening process, a list of papers 
representing 10% of the total that were excluded by the lead author were screened, considered and 
confirmed by a second author. A search of forward citations of the 22 potential inclusions resulted in the 
identification of one further paper for inclusion, giving a total of 23 systematic reviews potentially 
fulfilling the inclusion and exclusion criteria.  
 All 23 papers for potential inclusion went forward to full paper screening to be rated by the lead author 
as included, excluded or maybe. The other three authors independently assessed a subset of 7-8 papers 
each. Disagreements arose during this process concerning 4 papers and investigators deliberated and 
achieved final agreement. Six papers were included in the overview prior to quality assessment (Ciere, 
Cartwright, & Newman, 2012; Guo & Albright, 2018; Ma, Cheng, H. Y., Cheng, L. & Sit, 2019; McCabe, 
McCann, & Brady, 2017; Milavec Kapun, Sustersic, & Rajkovic, 2016; Tyack & Camic, 2017). Seventeen 
papers were excluded (See Table 1).  
The PRISMA diagram (Figure 1) details the search and selection process.  
Figure 1. PRISMA Diagram (insert about here) 
Quality appraisal 
We chose to adopt R-AMSTAR to assess the quality of the studies after reviewing a number of potential 
tools (GRADE, RE-AIM, MMAT and AMSTAR). The first three are designed for primary studies, mixed-
methods studies and randomized controlled trials (RCTs). AMSTAR is a measurement tool, with good 
content validity, for the assessment of multiple systematic reviews (Shea et al., 2007). As each 
component of the score measures a different domain of quality, the summary score is meaningful 
(Conway et al., 2013). AMSTAR was created for systematic reviews of RCTs, making it less appropriate 
for our overview. R-AMSTAR is a revised version of AMSTAR (Pollock, Fernandes, & Hartling, 2017; Shea 
et al., 2007). It detracts nothing from its content and construct validity and using the criteria originally 
employed in its development, it “yields numbers based upon generally agreed upon criteria of 
excellence, which can be transformed into a standardized grading system of the quality of the evidence 
presented in any given systematic review” (Kung et al., 2010) (p. 88). It has also been used by other 
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overviews in self-management of LTCs and telehealth (Captieux et al., 2018; Hanlon et al., 2017). 
(Details in Table 1.) 
The quality appraisal process was undertaken by the full research team in a standard manner by running 
blind critical R-AMSTAR assessments of the same systematic review and comparing the outcomes (See 
Table 1). A team decision was taken to exclude Milavec Kapun et al. (2016) based on a 15/44 (34%) 
quality rating. Uncertainty remained as to whether this scoring resulted from the paper’s poor 
methodology or reporting. It was unclear, for example, whether there was duplicate study selection and 
data extraction, and no list of included or excluded papers or table of characteristics were provided, 
among other limitations.  
Of the 5 included reviews, the quality of 3 (Ciere et al., 2012; Ma et al., 2019; McCabe et al., 2017) was 
high and 2 (Guo & Albright, 2018; Tyack & Camic, 2017) were of low quality (but only by 4 points or less). 
The overall review was of high impact given that the total participants approached 10,000. Two papers 
(Ma et al., 2019; McCabe et al., 2017) both scoring 40/44 (91%) stood out from the other reviews as 
they included hand-searching of the literature, had no language restriction and sufficiently stated the 
reasons for exclusion of articles seriously considered. Of these two reviews, McCabe et al. also provided 
the most comprehensive literature search, included grey literature, was unique in providing details of 
excluded records and articles, showed appropriate methods for combining studies, and addressed 
publication bias, conflict of interest and support statements most fully. 
The R-AMSTAR quality assessment is Additional file 2.  
Figure 2. Frequency distribution of R-AMSTAR scores (Insert about here) 
Data extraction 
Data extraction was carried out by one author and then checked and agreed by another. Extracted 
characteristics included: author (year, country), number of studies, study design, participant numbers 
and conditions, interventions/types of technologies, follow-ups, author’s conclusions, age, gender, 
patient population, condition details, sample sizes, interventions/control, research question, outcomes 
of interest, risk of bias assessment, evaluation of quality, drop-out rate and self-efficacy outcomes 
reported (patient activation, motivation, mastery, etc.). In case a review lacked study data, primary 
studies were consulted. Failing that, the investigators and the journal were contacted.  
Synthesis  
Data from the findings and discussions sections of all included papers were synthesized narratively and 
no statistical or meta-analysis was carried out. There was one overlap of research groups in the primary 
studies within the reviews. McCabe et al. (2017) cited Tabak et al. (Tabak, Vollenbroek-Hutten, van der 
Valk, van der Palen, & Hermens, 2014) and Guo and Albright (2018) cited Tabak et al. (2014) for 
different papers concerning two pilot studies for patients with COPD. 
RESULTS  
The results section is descriptively analytical. We first describe each review study’s characteristics, 
quality of primary studies, participant characteristics, intervention and technology characteristics, and 
follow-ups, attrition and drop outs. Outcomes of the research question are given and illustrated 
graphically. 
1. Individual review study characteristics 
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The characteristics of the 5 individual reviews are summarized in Table 2. They were published between 
2012 and 2019 with 3 conducted in the UK, one in the USA and one in Hong Kong. They reported a total 
of 74 studies of mixed design (17 RCTs, 31 clinical trials with experimental or quasi-experimental 
designs, 7 controlled design studies comparing 2 groups, 4 RCTs comparing a CG with either 2 or 3 IGs, 1 
pre-post observational design study, 14 mixed methods studies) involving 9,004 participants.  
The average number of primary studies included in the reviews was 14.8 (range 3-31). The 5 included 
reviews each addressed one of the included LTCs: heart failure (Ciere et al., 2012), hypertension (Ma et 
al., 2019), COPD (McCabe et al., 2017), dementia (Tyack & Camic, 2017) or a number of chronic 
conditions (Guo & Albright, 2018) which included one of these LTCs in enough studies to satisfy the 50% 
+1 rule (See Table 1). 
Table 2. Characteristics of Included Systematic Reviews (Insert about here) 
2. Quality of primary studies 
Authors of included reviews carried out their own quality check of their primary studies to determine 
risks of bias, evaluation of quality and attrition or drop-out rates. We summarize them here. 
Ciere et al. (2012) quality assessed using an adapted version of the Effective Public Health Practice 
Project’s (EPHPP) Quality Assessment Tool for Quantitative Studies (2019). The adapted tool included 26 
items assessing seven of the EPHPP’s eight domains plus three domains taken from Downs and Black’s 
checklist (Downs & Black, 1998). They reported that the overall quality of studies was poor with only a 
single study achieving a global rating of moderate. Weaknesses related to statistical power, blinding, 
selection bias, data collection, attrition, intervention integrity and statistical analyses.  
Guo & Albright (2018) referred to Cochran’s quality of evidence guideline and cited Littell (2008). They 
predominantly found biases to be low, unclear or high risk. The majority of included studies reported all 
studies’ pre-specified outcomes and were marked low risk for reporting bias. They found that a few 
studies ignored some selective outcomes and evaluated them as high risk. 
Ma et al. (2019) reported according to the PRISMA statement (Moher et al., 2009) and quality assessed 
one RCT with the Randomized Controlled Trial Checklist of Joanna Briggs Institute (Tufanaru, Munn, 
Aromataris, Campbell, & Hopp, 2017) and the Cochrane Handbook for Systematic Reviews of 
Interventions (Higgins & Green (Eds.), 2011). Meta-analysis conducted using Review Manager 5.3 for at 
least two studies reporting the same outcome. Otherwise, narrative synthesis was performed. They 
found “suboptimal quality and some methodological weakness, such as lack of clear information on 
randomised and allocation concealment and absence of blinding the outcome assessors” (p. 44).   
McCabe et al. (2017)  assessed with the Cochrane Handbook of Systematic Reviews of Interventions and 
found low, unclear or high risk. GRADE (Grading of Recommendations, Assessment, Development and 
Evaluations) offers an informative, transparent and structured system for rating quality, and developing 
and presenting summaries of evidence for systematic reviews and recommendations in health care (G. 
Guyatt et al., 2011; G. H. Guyatt et al., 2008). Using the five GRADE considerations (study limitations, 
consistency of effect, imprecision, indirectness, and publication bias), reviewers assessed overall low 
evidence quality of studies that contributed data to the meta-analysis. 
Tyack & Camic (2017)  assessed quality using Pluye and Hong’s (2014) Mixed Methods Appraisal Tool 
(MMAT) checklist and reported variable results - 25% (6 papers), 50% (1 paper), 75% (5 papers) and 
100% (5 papers). 
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3. Participant characteristics 
All reviews (or 50% +1 of their included studies) focused on older people. The mean age of participants 
was lowest for hypertension (50-68), followed by chronic conditions (average 55 years), heart failure 
(mean ages 61-78), COPD (average 64) and dementia (mean ages 74.3 - 84.5). Only one review met 
inclusion criteria for each of the chronic LTCs. 
All participants in the included reviews were either community-dwelling (living at home, which includes 
sheltered accommodation) or mostly involved people living at home (at least 50% +1 of the studies). 
Concerning setting, although telehealth by definition connects people from home with healthcare 
providers (HCPs) located elsewhere, Tyack (2017) reviewed studies of people with dementia and their 
carers at day centers or unspecified locations (only one specified that it was an ‘in-home pilot study’), 
and this technology was not connecting to remote HCPs. As paid (formal) and unpaid (informal) carers, 
an art therapist and a facilitator were involved in the interventions, the devices facilitated connection 
with on-site social care providers.  
4. Interventions and technology characteristics 
Similar to study design, technology interventions found in the review papers were highly heterogeneous 
and spanned 3 broad categories:  
 Transfer of clinical information from patient home-health monitoring of signs and symptoms 
using long-distance communication technologies: via a home telehealth system (Ciere et al., 
2012; Guo & Albright, 2018), Health Buddy (Ciere et al., 2012), smartphone (Guo & Albright, 
2018; Ma et al., 2019; McCabe et al., 2017), computer (Guo & Albright, 2018; Ma et al., 2019; 
McCabe et al., 2017), TV (Guo & Albright, 2018), tablet (Ma et al., 2019; McCabe et al., 2017), 
touchscreen devices (Tyack & Camic, 2017), iPad (McCabe et al., 2017; Tyack & Camic, 2017), 
website (Ciere et al., 2012; Ma et al., 2019), apps (Ma et al., 2019; McCabe et al., 2017), 
videophone/Skype (Ciere et al., 2012; Guo & Albright, 2018; McCabe et al., 2017), personal 
digital assistance tools (Ma et al., 2019), compliance monitoring device (Ciere et al., 2012), 
‘system generating feedback by using automated email reminders’ (Ma et al., 2019) (and 
telephone as part of a combined strategy) (Ciere et al., 2012). 
 Interventions comprising behavioral change through education dissemination, tele-education or 
home nurse visits (as part of a combined strategy): ‘health care providers supporting 
individualized goal-directed feedback through multiple media (website, SMS, email, mobile apps 
such as WeChat, and telephone call)’ (Ma et al., 2019); network applications accessible over the 
internet, including blogs, discussion boards, online multimedia and online surveys (Guo & 
Albright, 2018) 
 A telehealth program applying multiple telehealth technologies (Guo & Albright, 2018) 
Telehealth intervention strategies included monitoring of signs or symptoms (Ciere et al., 2012; Guo & 
Albright, 2018; Ma et al., 2019), lifestyle modification techniques such as goal-setting and decision-
making (Ma et al., 2019), motivation (Ma et al., 2019), engagement (Guo & Albright, 2018; Tyack & 
Camic, 2017), education (Ciere et al., 2012; Guo & Albright, 2018; Ma et al., 2019) and maintenance (Ma 
et al., 2019).   
Some studies required participants to use the device in a stated frequency (Ciere et al., 2012; Guo & 
Albright, 2018) such as 2 or 3 times a week, or did not specify frequency of use (Ciere et al., 2012). One 
fully-automated system specified the level of email interaction required and one system generated 
automated emails (Ma et al., 2019).  
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Comparator interventions included standard/routine/usual care (Ciere et al., 2012); home nurse visits 
(Ciere et al., 2012); face-to-face and/or hard copy digital documentary education/self-management 
support (McCabe et al., 2017); regular visits to outpatient clinics (Ciere et al., 2012);  hospital follow-up 
by nurse and cardiologist (Ciere et al., 2012); counselling, training, education or information on disease-
specific self-care behavior (Ciere et al., 2012); care as directed by primary care provider (Ciere et al., 
2012); keep paper-based record of blood pressure (Ma et al., 2019); and Nurse Standard hypertension 
care, check BP 3-5 times a week, communication through office visit, phone calls, email (Ma et al., 
2019). 
5. Follow-ups and attrition/drop outs 
Attrition or drop-out rates were not specifically reported in all 5 papers, hence it was not possible to 
compare. However, attrition bias was addressed in terms of the quality of the reviews. Attrition bias is 
caused by the amount, nature or handling of missing outcome data or failure of follow-up. A rule of 
thumb states that <5% attrition leads to little bias, whilst >20% poses serious threats to validity (Schulz 
& Grimes, 2002). We summarize follow-ups, attrition and drop-out rates in Table 3 (further detailed 
characteristics in Supplemental file #4) 
Table 3. Follow-ups, attrition and drop-out rates (insert about here) 
6. Outcomes 
Research questions and outcomes sought mentioned ‘self-efficacy’ or related terms, or investigated a 
general topic containing the concept. These are summarized in Table 2. 
We found that evidence for self-care telehealth technology supporting self-efficacy of older people with 
LTCs living at home was limited. Given the paucity of research that fit the inclusion criteria, it was not 
surprising to find such heterogeneity of data and study design, a common finding among systematic 
reviews of healthcare interventions in real-world settings. Lack of standardization does represent a 
factor that hampers the possibility of summarising quantitative data and drawing general assumptions 
because heterogeneity rules out the pooling of studies. In this case, a meta-analysis was inappropriate 
due to the heterogeneity of the data and study designs, hence a narrative synthesis was conducted.  
Perhaps due to the heterogeneity, each paper offered an interesting contribution to the question. Figure 
3 graphically illustrates the main findings which are addressed in more detail below. 
Figure 3. Main Findings (insert graphic about here) 
7. Findings on self-efficacy 
Ciere et al. (2012)  examined whether improvements in clinical outcomes and quality of life (QoL) are 
mediated by increases in knowledge, self-efficacy and self-care behavior in patients with heart failure. 
Two plausible pathways (increased monitoring by HCPs and improved self-care by patients) were 
suggested by which telehealth achieves apparent improvements. A model of self-care behavior and two 
of its cognitive precursors (knowledge and self-efficacy) was proposed with 6 pathways by which 
telehealth might lead to improved outcomes. In 12 studies, 2 self-efficacy pathways were reported, but 
none robustly. 
 Relationships between telehealth and self-efficacy – 6 of the 12 studies assessed the effect of 
telehealth on self-efficacy or confidence relating to the performance of self-care behaviors; 3 
reported no change over time; 3 found improvements across both intervention and control 
groups; 5 RCTs analyzed group differences at follow-up (one found improved self-efficacy 
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relative to controls; two found no group differences; and two studies comparing multiple 
intervention arms found some group differences but none between telehealth and controls) 
 Relationships between self-efficacy and self-care behavior – One RCT examined associations 
between self-efficacy and seven self-care behaviors separately for telehealth and a control 
group at 6 weeks and 3 months. Only two of 28 associations tested were significant and none 
were significant at 3 months. A second RCT assessed the relationship between confidence to 
perform self-care behaviors and (self-reported) performance of nine self-care behaviors. 
Associations involving five self-care behaviors were significant at 120 days but associations for 
the remaining four behaviors were non-significant. 
This study highlighted plausible pathways between telehealth and outcomes specific to self-efficacy and 
knowledge, but these are poorly theorised and rarely investigated in the literature. This impedes our 
understanding of how telehealth might achieve beneficial outcomes. 
Guo & Albright (2018) found studies suggesting self-care success in heart failure (medication 
adherence), chronic diseases (health-problem skills, self-care efficacy and medication compliance 
knowledge), COPD (QoL) and hypertension (improving health-care management skills).  
 Fourteen studies of long-distance communication technologies (LDCs - programs or technologies 
supporting interactions/communications between HCPs and patients over distances, e.g. 
cellphone/videophone); an efficient strategy for HCPs to mentor and assist patients, saving time 
and cost for both. 
 Three studies of web-based technologies (WBTs - network applications accessible via Internet: 
blogs, discussion boards, online multimedia/surveys); effective in improving self-care skills, 
empowering patients and improving self-efficacy. 
 Nine studies of home-health monitoring systems (HHMSs - patients monitor health factors like 
blood pressure from home, sharing information electronically with HCPs); suggested to be 
effective on promoting medication adherence and QoL. 
 Four studies of tele-education technologies (TETs – HCPs deliver patient education via the TV); 
effective at promoting non-medical self-care behaviours, e.g. mind–body exercises 
 One study of a telehealth programme applied all the above (LDC, WBT, HHMS and TET).  
Telehealth technologies improved self-monitoring and hence were effective at helping heart failure 
patients control weight and COPD patients increase daily physical activity. Evidence was found for the 
linkage between consistent communication between patients and HCPs and telehealth effectiveness. 
Poor persistence of telehealth’s effectiveness was also found and attributed to waning enthusiasm over 
time. 
Ma et al. (2019) reported lifestyle modification techniques (goal-setting, decision-making, provision of 
feedback, self-monitoring and motivational interviewing) which can achieve a healthy lifestyle for 
hypertensive patients, decrease sodium intake and increase medication adherence and maintenance. 
Interventions involved a website, a blood pressure (BP) home-telemonitoring system for uploading 
readings, an individualized BP goal and telephone calls with a pharmacist. Electronic health charts were 
used for decision-making about medication, diet, exercise and stress management. Goal-setting used an 
ehealth device and website which promoted patients’ motivation and knowledge by providing 
programmed feedback. Technologies such as personal accounts and individualized reminders facilitated 
patient motivation and maintenance whether health care providers were involved or not. A combination 
of these components was effective and recommended to promote adherence. 
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While McCabe et al. (2017) sought self-efficacy outcomes in COPD, they found that no studies measured 
self-efficacy (nor cost-effectiveness, functional capacity, lung function, or anxiety and depression).  
Tyack & Camic (2017)  sought psychological well-being outcomes broadly (rather than the self-efficacy 
of the person with dementia specifically), including related outcomes such as carer burden and 
independence of the person with dementia. They found evidence for benefits in mental stimulation, 
mood and mental health, greater engagement and quality of interaction, increased activity levels, 
improvement in quantitative well-being, social interaction, relationships and wider social impacts, as 
well as self-mastery, which maps most closely to self-efficacy. Evidence for empowerment, increasing 
usage frequency, improvement in participants’ performance, confidence in cognitive abilities, more able 
to express feelings, spontaneous touching of the screen and interacting with the device all point to 
engagement and mastery of the intervention. One study found no significant impact on depressive 
symptoms or on QoL. When used with appropriate planning and support, touchscreen interventions 
were able to support the personhood of the person with dementia by engaging in meaningful activities, 
sharing social interactions and mastering new skills independently. Important procedural aspects 
included provision of support. Clinical implications that further the potential for self-efficacy included 
challenging prevailing beliefs of clinicians and others that people with dementia are unable to use 
touchscreen technologies, and offering the technology earlier on in the progression of dementia.   
Main findings 
1. Self-efficacy was rarely included in outcomes of telehealth interventions for older people, or it 
was characterized and measured without underlying mediators such as support or education. 
2. There is a plausible pathway from telehealth to self-efficacy but patient benefits for LTCs are 
dependent on telehealth modes (either individually or in combination) and techniques. 
3. Increased self-care and self-monitoring empower patient-activation, motivation or mastery. 
DISCUSSION and IMPLICATIONS 
To our knowledge, the present overview of systematic reviews is the first to synthesize systematic 
reviews of the extent to which telehealth supports self-efficacy of older people with LTCs living at home. 
By using the Revised-AMSTAR tool for quality assessment we found 3 high quality reviews (initially out 
of 6). This overview “relies on the quality of the reporting found in not only the reviews themselves, but 
also the primary research studies included within them” (McBain, Shipley, & Newman, 2015) (p. 8). 
Quality was variable as evidenced with standardized tools. What follows is a critical reflection of the 
relevance of these findings to studies in the literature.  
A review by Wonggom et al. (2019) on avatar-based technology in patient education showed improved 
self-efficacy in 3 of 8 studies of patients with chronic diseases, but like other excluded studies it did not 
specifically address older people with the included LTCs.  
Health outcomes and efficacy for persons with MCI, Alzheimer disease, and dementia have been 
likewise under-investigated. Bateman et al. (2017) found only cognition, function, mood, and quality of 
life for mHealth app interventions. Whilst 58% of 24 studies showed some degree of efficacy, self-
efficacy was examined in only one study showing no improvement in outcome. Even though we found 
no systematic review examining interventions considering the self-efficacy of the person with dementia 
as a specific outcome, numerous reviews focused on the caregiver. These included a meta-analysis by 
Huis In Het Veld, Verkaik, Mistiaen, van Meijel and Francke (2015) reporting evidence for the 




The nature of dementia is starkly different from other LTCs in terms of the declining ability of the person 
to activate and motivate independently. Hence, this overview reflects that distinction by including care 
partners, for whom health-promoting self-care behavior may be limited by several factors which in turn 
affect their own health (Oliveira, Zarit, & Orrell, 2019), but still keeping the focus on the person with 
dementia themselves. Similarly to Tyack & Camic (2017), a review by Joddrell & Astell (2016) found that 
people with dementia were able to use touchscreen technology independently, to navigate the screen, 
store and charge the device. Seven of 45 studies reported positive factors associated with independent 
use.  
Mediating factors supporting self-care are now better understood generally (Fredericks, Martorella, & 
Catallo, 2015), in heart failure (Clark et al., 2016), hypertension (Band et al., 2017; Saksena, 2010; Shahaj 
et al., 2019) and COPD (Murphy et al., 2017). However, whilst Guo and Albright (2018)  found a linkage 
between communication and telehealth effectiveness, the usual absence of such mediating factors 
underscores Ciere et al.’s lack of pathway findings (2012), especially as they relate to self-efficacy in 
older people. It is important to measure and report if and how self-efficacy mediates clinical outcomes, 
because as McBain et al. (2015) suggest, “engaging and empowering patients with a chronic condition to 
adjust their treatment and lifestyle themselves in response to monitored data, may be a more successful 
route to improving outcomes as opposed to the healthcare professional leading this decision” (p.8).  
Furthermore, in a dissertation in which telemonitoring was associated with improved self-efficacy for 
patients with COPD and heart failure, West-Frasier (2008) urged the inclusion of emotional well-being 
and self-efficacy measures so practitioners are able to provide interventions that improve emotional 
health, “and empower patients to improve self-care management” (pg. 152). Lastly, our findings support 
those of Gaveikaite et al. (2019) in identifying the need to include such outcomes in future empirical 
research reporting and in advocating for improved telehealth trial designs by “focusing on the entire 
intervention’s adoption process evaluation” (p. 78).  
Limitations of the current study 
This overview found a common disparity between quantitative papers examining and reporting clinical 
outcomes and qualitative papers delving into the reasons (barriers, facilitators, etc.) underlying actions 
of patients. Such papers are often published separately in different journals making comprehensive 
understanding of an intervention and its outcomes challenging for reviewers who wish to draw together 
conclusions about self-management of a chronic condition for a particular demographic.   
Overviews of systematic reviews have unique features requiring different or additional methods (Lunny, 
Brennan, McDonald, & McKenzie, 2018). Within an overview if there is substantial overlap of included 
primary research studies this may introduce bias into the reviewing process. This was not evident here 
given that only one cross-over was found - one study in two different papers. Also, quality and risk of 
bias were assessed and there were no discordant results across reviews.  
However, selection bias may have been introduced during the first stage of article selection carried out 
by one author, even though a percent of the excluded papers were considered and confirmed by a 
second author. A further limitation is the inclusion of studies which reported average/mean age as this 
probably includes people <50 years old. Due to a lack of consensus on the terminology for self-efficacy 
and telehealth, papers may have been missed. Lastly, limiting selection to English only papers may have 




We aimed to understand what the existing evidence-base was for how health technology can support 
self-efficacy of older people with specific LTCs. Although there is a plausible pathway from telehealth to 
self-efficacy, patient benefits depend on telehealth modes and techniques. We identified self-efficacy, 
patient-activation or mastery as critical for empowering patients to adopt telehealth, and hence to the 
success of self-care in LTCs. We therefore conclude that the invisibility of self-efficacy, patient-activation 
or mastery as outcomes is a limitation, with implications for policy, practice and research. 
Implications for policy and practice – With the shift towards more widespread use of TH there is 
increasing evidence that supporting self-management underlies patient self-efficacy. However, if the 
means whereby this has been achieved is missing in research reports, or is obscured across several 
publications, then clinicians, technologists and interventionists remain unclear about how exactly to 
improve or enhance self-managed healthcare using telehealth. Meanwhile, in the UK and many high-
income countries, telehealth is being seen by governments as key in helping to address the rising costs 
of care for older people. While substantial investments are being made in telehealth, and the NHS 
promotes a key role for patient-activation in supported self-management of personalised care, our 
overview has shown that the evidence base for self-care telehealth technology supporting self-efficacy 
of older people with LTCs living at home is relatively thin.  
Implications for research – To address these gaps in knowledge and to inform a better understanding of 
what works well, research needs to report:  
 Detailed information about the logistics of intervention implementation, including the degree of 
intensity, duration and type of interventionist contact using PRISMS taxonomy (Pearce et al., 
2016; Taylor et al., 2014) 
 Attrition and drop-out rates along with insight into the ‘why’ of the numbers  
 Impact of intervention over an extended timeframe, including follow-ups 
In this way, useful findings may be included in future research reporting and in advocating for improved 
telehealth trial designs with enhanced process evaluation. In conclusion, greater integration between 
research and practice will potentially benefit both, and ultimately keep patients at the center of care.  
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Table 1. Design and Methods 
 
LITERATURE SEARCH 
Use of PICOS In formulating the scope, use of PICOS “can help the reviewers to delineate 
clearly… to compare and summarise systematic reviews that address the 
same treatment comparison or a particular intervention for a population 
or condition, or a range of interventions for people with a specific 
condition” (Smith, Devane, Begley, & Clarke, 2011). Polanin, Maynard and 
Dell (2017) also recommend, “the research question should follow the 
PICOS format, specifying the population, intervention, comparison 




on the initial 
scoping 
This phrase, adopted by the Cochrane Database of Systematic Reviews as 
early as 2011 is increasingly used in healthcare (Bialy et al., 2020; Lee, 
Choi, & Hyun, 2019; Shepherd et al., 2018; Zhong et al., 2020) and 
methodology (Lunny et al., 2018; Polanin et al., 2017). Smith, et al. (2011) 
stated, “conducting a systematic review of reviews highlights the 
usefulness of bringing together a summary of reviews in one place, where 




Proposed by Bandura (1977; 1986), self-efficacy influences the amount of 
effort put forth and the choice to act while facing obstacles and failure. If 
people lack belief, they lack incentive to act (West-Frasier, 2008). 
Expectations of self-efficacy determine whether an individual will be able 
to exhibit coping behavior, and in the face of obstacles, how long effort will 
be sustained. A recent study by Choi, Dabelko-Schoeny, Lee and Bunger 
(2020) illustrated “the importance of individuals’ self-efficacy and reveal 
the positive mediating role of engagement when promoting older workers’ 
mental health”, further supporting “the active role older adults play in 
enhancing their overall well-being” (p. 6). 
Selection criteria: 
Explanation and 
use of “50% + 1” 
rule 
>50% criteria explained – During the searches we did not limit by age as 
many reviews included a mixed demographic and we did not want to miss 
key papers. We found a paucity of reviews in which the demographic was 
limited exclusively to older people. Where different age groups were 
involved in a study, to be included there needed to be clearly written up 
results that were specific to the age cohorts and LTCs we were looking at. 
Hence, we took an evidence-based decision to include studies that had 
older people forming the majority of the sample. ‘Majority’ has been 
defined in the literature (Milligan et al., 2015) as fifty per cent plus one 
(50% +1) of participants in the sample, regardless of sample size. This 
became the age criteria. We could therefore include studies in which at 
least 50% +1 of the primary studies included people 50 years or older. The 
50% +1 rule was also applied to the LTCs (at least 50% +1 of the LTCs in the 
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review must be heart failure, COPD, hypertension or dementia or a 
combination of these). 
Electronic 
database search 
These were searched in June 2016 and updated in October 2019:  
 PubMed 
 EMBASE 
 CINAHL, PsycINFO  
 Cochrane Database of systematic Reviews 
 Web of Science 
 Science Citation Index Expanded (SCI-EXPANDED) 
 UK NHS Health Technology Assessment 
 University of York Centre for Reviews and Dissemination database 




These 17 were excluded following full paper screening of 23 papers: 
(Band et al., 2017; Clark et al., 2016; de Jong, Ros, & Schrijvers, 2014; 
Fredericks et al., 2015; Hanlon et al., 2017; Joddrell & Astell, 2016; 
Lancaster et al., 2018; Maeder, Poultney, Morgan, & Lippiatt, 2015; 
Morton et al., 2017; Pare, Jaana, & Sicotte, 2007; Saksena, 2010; Shahaj et 
al., 2019; Stellefson et al., 2013; Van der Roest, Wenborn, Pastink, Droes, 
& Orrell, 2017; van Santen et al., 2018; Wonggom et al., 2019) were 
excluded due to:  
 missing a desired outcome (Fredericks et al., 2015; Van der Roest 
et al., 2017; van Santen et al., 2018);  
 participants being younger than age criteria (Lancaster et al., 2018; 
Saksena, 2010);  
 ages not being reported (Morton et al., 2017; Shahaj et al., 2019);  
 being a service evaluation (Maeder et al., 2015);  
 a focus on intervention development, rather than research 
outcomes (Band et al., 2017);  
 focusing on excluded LTCs, often diabetes (Hanlon et al., 2017; 
Pare et al., 2007; Stellefson et al., 2013; Wonggom et al., 2019); 
 not focusing on health technology and/or the study was carried 
out in a non-domiciliary setting (e.g. a hospital or clinic) (Clark et 
al., 2016; de Jong et al., 2014);  
 review was not systematic (i.e. no dual data-extraction) (Joddrell & 
Astell, 2016). 
Quality appraisal: 
Use of R-AMSTAR 
AMSTAR was argued by Kung, et al. (2010) to not produce quantifiable 
assessments of systematic review quality and clinical relevance. To clarify, 
this means that R-AMSTAR can quantify the quality of systematic reviews 
resulting in a scoring of quality components. In this way, study quality can 
be easily compared. Although both AMSTAR and R-AMSTAR produced 
comparable quality ratings (Dosenovic et al., 2018), the research team took 
the view that R-AMSTAR was more appropriate for our heterogeneous 
study designs, had a clear and greatly enlarged set of appropriate 
questions (11 separate domains with a total possible score of 44 instead of 
11), an effective quality scoring system - a quality rating of low (<30) and 
high (≥30), and a quantitative definition of lower impact studies (i.e. 
participants <1000).  
Blind critical 
assessments 
Three investigators each scored 2 papers whilst the first author scored all 6 
papers. Scoring was shared in a team meeting and any divergent response 
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population, age & gender 
(mean, median or range)  
Number of studies, study design; 
intervention group (IG); control 
group (CG) 
Mode of delivery; Personnel delivering 
support; Intensity, frequency & duration 
Research question, outcomes of 
interest   
Self-efficacy outcomes reported (patient 





888 adults with heart 
failure, mostly mild/ 
moderately impaired; 
Some w/ none or severe 
impairment; Sample sizes 
18 to 284 (median age 74, 
mean age 61–78); 3 studies 
focused on older heart 
failure patients; 1 on 
coronary artery bypass 
graft surgery patients. 
12 studies: 11 w/ comparator: 6 w/ 
standard, usual or routine care; 7 
controlled studies reported 
baseline severity of heart failure 
(TH IG vs. standard care) 
Remainder were RCTs comparing 
CG w/ 2 or 3 IGs. One study: pre-
post observational design.  
Three w/ home nurse visits; variable content of 
care in other 9. Duration: 6 wks - 12 mos 
(median 3 mos); clinical info transferred via 
home TH system, telephone, website, 
videophone or a compliance monitoring 
device; patients mostly used technology daily; 
patient monitoring of signs and symptoms; 
nine studies also involved education.  
Evidence for mediating role of 
knowledge, self-efficacy or self-care in 
relationship between TH and patient 
outcomes. Measures of association 
directly or indirectly reflecting 6 
pathways: TH and knowledge; 
knowledge and self-care; TH and self-
efficacy; self-efficacy and self-care; TH 
and self-care; self-care and patient 
outcomes (HRQoL or clinical markers).  
Nine studies reported effect of TH on self-
reported self-care behaviour. In 6, TH improved 
self-care behaviour from 4 weeks to 12 months. 
Most frequently they were group or pre-post 
intervention differences on knowledge, self-
efficacy, self-care or patient outcomes. Six 
assessed self-efficacy or confidence relating to 
performance of self-care behaviours. Three found 
no change; 3 improved self-efficacy across IG and 
CGs. One RCT examined associations between 
self-efficacy and 7 self-care behaviours: 2 out of 
28 were significant, none at 3-months. One 
examined confidence to perform self-care 





4137 Older adults w/ heart 
failure, hypertension, 
diabetes, pain, COPD, lung 
disease, rheumatoid 
arthritis or other chronic 
conditions.  Avg age 55+ 
years. 
31 Clinical trials (experimental 
designs or quasi-experimental 
designs); Sample sizes (20 - 478; 
median 101; only 2 CGs are 
mentioned. 
Studies: 14 long-distance communication 
technologies (LDCs), 3 web-based technologies 
(WBTs), 9 home-health monitoring systems 
(HHMSs), 4 tele-education technologies (TETs) 
and 1 TH programme applying multiple 
technologies.  
Effects of TH technologies on self-
management: improving self-care 
skills, self-monitoring behaviours or 
clinical outcomes 
Findings document the feasibility of TH 
technologies in benefitting participants’ self-care, 
including self-care efficacy, health-care knowledge 
and adherence to self-care behaviours. Studies 
suggested success in heart failure (medication 
adherence), chronic diseases (health-problem 
skills, self-care efficacy and medication 
compliance knowledge), COPD (QoL) and 




2019)                          
Hong 
Kong 
3998 with Hypertension, 
mean age 50-68, eight 
studies had >50% men 
14 RCTs; Sample size ranged from 
44-778. IG total = 2,148; CG total = 
1,948 
eHealth interventions - devices featuring 
interactive wireless communication capability, 
operating web-based applications with high 
portability; eHealth interventions - self-care, 
SM, self-care behavioural change or education 
dissemination; eHealth strategies - blood 
pressure monitoring, lifestyle modification 
techniques, motivation and maintenance. Four 
studies stated device usage frequencies and 
dosages. Others encouraged 2-3x/wk. A fully-
automated system set patient-device 
interaction ≥ 8 emails.  
Delivery modes and strategies of 
eHealth and effectiveness on physical 
outcomes (systolic/diastolic BP, BP 
control, body mass 
index/weight/cholesterol), self-care 
behavioural (medication adherence, 
sodium intake, healthy diet, physical 
activity, smoking, alcohol consumption) 
and psychosocial well-being (anxiety, 
stress, depression and quality of life). 
Regarding self-care behavioural outcomes, the 
pooled results show that eHealth interventions 
significantly reduced the sodium intake. In 
comparison with blood pressure control results, 
self-care behavioural outcomes were inconclusive. 
Their effectiveness on self-care behavioural 
change and psychosocial well-being is insufficient. 
A few studies measured behavioural outcomes 
probably because of limited interventions and 







557 participants with COPD  
Avg age 64 years; 64.9% 
men 
3 RCTs; IG: 319 people received 
smart technology to support SM; 
CG: 238 received face-to-face 
verbal/written or digital 
information and education about 
SM  
RCTs were included that measured effects of 
remote and Web 2.0-based interventions: 
technologies included personal computers 
(PCs) and applications for mobile technology 
(iPad, Android tablets, smart phones, Skype, 
etc.) on behavioural change towards SM of 
COPD. Comparator interventions included 
face-to-face and/or hard copy/ digital 
documentary educational/self-management 
support.  
Effectiveness of computer and mobile 
technology versus face-to-face or hard 
copy/digital documentary-delivered 
interventions, or both, in facilitating, 
supporting, and sustaining SM. 
Primary: hospital admissions; acute 
exacerbations; health-related HRQoL; 
Secondary: self-efficacy; cost-
effectiveness; functional capacity; lung 
function; anxiety and depression; 
sustained behaviour changes 
This review had nine defined outcomes and found 
only five. None of these studies included 
outcomes such as self-efficacy, cost-effectiveness, 






312 people with dementia 
Mean ages 74.3 - 84.5, ages 
reported in half of the 
studies; People with 
dementia and/or their 
carers (informal carers, 
care staff, art therapists or 
facilitators). Sample sizes 2-
40 (median 12) 
16 papers, 14 interventions: 
qualitative explorations; system or 
informal evaluations; repeated 
measures; effectiveness 
evaluation; case-control design; 
interviews; case/pilot studies; 
group sequential quasi-
experimental design; pragmatic 
mixed methods concurrent nested; 
pre-post and mixed methods field 
tests  
Touchscreen-based interventions designed for 
use by people with dementia, with a specific 
focus in assessing their impact on well-being.  
Psychological well-being impact or 
outcomes of touchscreen-based 
interventions (including carer burden 
and independence of people with 
dementia); Identifying relevant 
theories and key aspects of these 
interventions 
Existing research is small-scale; touchscreen-
based interventions can improve psychological 
well-being of people with dementia; reportedly 
benefits mental health, social interaction and 
sense of mastery; reportedly benefits informal 
carers' perceived burden and quality of 
relationship. Key aspects: user interface, support 
provision, learning style, tailored content, 
appropriate challenge, ergonomics and users’ 
dementia progression. Intervention delivery and 
outcome measurements inconsistent.  
Acronyms: BP – Blood pressure; CCQ - Clinical COPD Questionnaire; CG - control group; HCP - health care provider; HHMS - home-health monitoring system; HRQoL -  health-related quality of life; HT - Hypertension;  IG - 
intervention group;  LDC - long-distance communication technology; MTP - telehealth programme applying multiple telehealth technologies; PA - Physical activity; PRISMS - Practical Reviews in Self-Management Support; RCT - 






Table 3. Follow-ups, attrition and drop-out rates  
Study Follow-ups Attrition / drop-out rates 
(Ciere et al., 
2012)  
2 to 12 months after trial started Studies rated poor for reporting of attrition 
(Guo & 
Albright, 2018)  
1/3rd reported follow-ups; from 3 to 12 months Attrition bias rated Low-Risk (20 studies), 
Unclear Risk (7) and High-Risk (4) 
(Ma et al., 
2019) 
4 out of 14 completed follow-up Drop-out rates: 0.67% to 20.67% which 
influenced the attrition bias.  
(McCabe et al., 
2017)  
Completeness of follow-up ranged from 75% to 86%  IG rates: 6% to 25%; CG rates: 0% to 17% 
(Tyack & 
Camic, 2017)  














































Supplemental file 1 – Search strategy  
After the scoping review exercise using PICOS (Participants, Interventions, Comparators, Outcomes and 
Study design) we decided not to include a search for Person or their Location (ie older people, 50+ 
living at home) as it missed too many relevant papers, but to focus instead on (#1) condition, (#2) 
intervention, (#3) study design (systematic review) and (#4) desired outcome, and then to (#6) exclude 
with NOT. 
Key text and MeSH (Medical Subject Headings) terms; Boolean/phrase in Title/Abstract; No limit on 
publication dates. 
 PubMed 
#1 in [Title/ 
Abstract] 
chronic disease* OR "chronic illness*" OR COPD OR hypertension OR "heart 
failure" OR dementia OR "chronic obstructive pulmonary disease" OR  chronic 
disease[MeSH Terms] OR  diseases category/therapy[MeSH Terms] OR 
"prevention and control"[MeSH Subheading] OR "therapeutic use"[MeSH 
Subheading] OR monitoring, physiologic[MeSH Terms] 
 
#2 in [Title/ 
Abstract] 
application OR apps OR "assistive technology" OR "blood pressure" OR CANTAB 
OR "CANTAB Mobile" OR "cardiac rehabilitation" OR "cell phone" OR "cellular 
phone" OR "chronic disease management" OR "computer-assisted instruction" 
OR device OR devices OR "digital biomarkers" OR "digital tool" OR ehealth OR E-
health OR "electronic health" OR "Florence" OR gerontechnology OR "healthcare 
technology" OR "health behavior" OR "health behaviour" OR "health care" OR 
healthcare OR "healthcare technology" OR "healthcare technologies" OR "health 
promotion" OR "Health Watch" OR "heart rate" OR "House of Memories" OR 
"information technology" OR interface OR internet OR ICT OR iPad OR "mhealth" 
OR M-health OR "memory assessment" OR "memory test" OR "mobile 
application" OR "mobile health" OR "mobile technology" OR monitor* OR 
"Motiva" OR "NHS simple" OR online OR "online intervention" OR "patient 
education" OR prompt OR pulse OR remind* OR "smart phone" OR smartphone 
OR "social network" OR SMS OR "social networking" OR technologies OR 
technology OR telecare OR telehealth OR tele-health OR telemedicine OR 
telemetry OR telemonitor* OR "text message" OR "text messaging" OR 
thermometer OR "uMotif" OR video OR wearables OR "wearable technology" OR 
wifi OR wireless OR "consumer health information technology" OR CHIT OR 
assistive technology[MeSH Terms] OR "communications media/therapeutic 
use"[MeSH Terms] OR "self management"[MeSH Terms] OR home care 
services[MeSH Terms] OR "self help devices/therapeutic use"[MeSH Terms] OR 





#3 in [Title/ 
Abstract]  
"systematic review" OR meta-analysis OR "systematically reviewed" OR 
systematic* OR "umbrella review" OR review*  OR metareview OR meta-review 
OR review literature as topic[MeSH Terms] 
 
#4 in [Title/ 
Abstract] 
"participant engagement" OR "patient knowledge" OR "patient skills" OR 
"confidence" OR "self activation" OR self-care OR "self care" OR self-help OR 
"patient activation" OR "self-management" OR self-efficacy OR "self efficacy" OR 
"self management" OR self-management OR mastery OR motivation OR "self-
activation" OR empowerment  OR  self efficacy[MeSH Terms] OR 
empowerment[MeSH Terms]  
 
#5   #1 AND #2 AND #3 AND #4 
 
#6 #5 NOT  
in [Title] 
robot OR robotic OR Paro OR "smart home" OR surveillance OR alarm OR alarms 
OR CCTV OR "falls detection" OR "fall detection" OR safety OR "baby monitor" OR 
webcam OR "scoping review" OR "integrative review" OR "realist review" OR drug 
OR drugs OR "risk reduction" OR guidelines OR corrigendum OR fractures OR 
depression OR alcohol OR stroke OR pain OR cancer OR constipation OR obesity OR 
"sleep apnea" OR "sleep apnoea" OR ulcers OR HIV OR HIV/AIDS OR diabetes OR 
diabetic OR wounds OR "adverse effects" OR "macular degeneration" OR toolkit 
OR reflux OR bleeding OR incontinence OR insomnia OR conference OR 
osteoporosis OR angina OR statement OR smoking OR screening OR statin OR 
statins OR influenza OR vaccine OR vaccines OR vaccination OR abortion OR 
hospital OR hospitalised OR hospitalized OR memorandum OR renal OR kidney OR 
liver OR "critical care" OR "data set" OR subcommittee OR diarrh* OR oncology OR 
sepsis OR "physical activity" OR supplements OR "combination therapy" OR 
hepatitis OR walking OR therapy OR therapies OR eating OR treatment OR 









Supplemental file #2 – R-AMSTAR Quality assessment 
R-AMSTAR - Revised AMSTAR - a measurement tool to assess the methodological quality of systematic reviews 
Taylor, S. J. C., et al. (2014). A rapid synthesis of the evidence on interventions supporting self-management for people with long-term conditions: 
PRISMS - Practical systematic Review of Self-Management Support for long-term conditions. Health Services and Delivery Research Southampton 
(UK), NIHR Journals Library 
 
Pearce, G., et al. (2016). "The PRISMS taxonomy of self-management support: derivation of a novel taxonomy and initial testing of its utility." J Health 
Serv Res Policy 21(2): 73-82. 
 
Kung, J., et al., 2010. "From Systematic Reviews to Clinical Recommendations for Evidence-Based Health Care: 
Validation of Revised Assessment of Multiple Systematic Reviews (R-AMSTAR) for Grading of Clinical Relevance."  
























































Shea, B. J.,et al., 2007. "Development of AMSTAR: a measurement tool to assess the methodological quality of 
systematic reviews."  BMC Med Res Methodol 7:10. doi: 10.1186/1471-2288-7-10. 
 
1. Was an ‘a priori’ design provided? 
     
   
 
Criteria: 
     
   
 
(A) ‘a priori’ design 1 1 1 1 1 1   
 
(B) statement of inclusion criteria 1 1 1 1 1 1   
 
(C) PICO/PIPO research question (population, intervention, comparison, prediction, outcome) 1 1 1 0 0 0   
 
Satisfies 3? score 4       2?=score 3       1?=score 2      0?=score 1 4 4 4 3 3 3  21 
 
      
   
2. Was there duplicate study selection and data extraction? 
     
   
 
Criteria:         
 
(A) There should be at least two independent data extractors as stated or implied. 1 1 1 0 1 1   
 
(B) Statement of recognition or awareness of consensus procedure for disagreements. 1 1 1 0 0 1   
 
(C) Disagreements among extractors resolved properly as stated or implied. 1 1 1 0 0 1   
 
Satisfies 3? score 4       2?=score 3       1?=score 2      0?=score 1 4 4 4 1 2 4  19 
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3. Was a comprehensive literature search performed?         
 
(A) At least two electronic sources should be searched. 1 1 1 1 1 1   
 
(B) The report must include years and databases used (e.g. Central, EMBASE, and MEDLINE). 1 1 1 1 1 1   
 
(C) Key words and/or MESH terms must be stated AND where feasible the search strategy outline should be 
provided such that one can trace the filtering process of the included articles. 0 1 1 1 1 1   
 
(D) In addition to the electronic databases (PubMed, EMBASE, Medline), all searches should be supplemented 
by consulting current contents, reviews, textbooks, specialized registers, or experts in the particular field of 
study, and by reviewing the references in the studies found. 0 0 1 0 1 0   
 
(E) Journals were “hand-searched” or “manual searched” (i.e. identifying highly relevant journals and 
conducting a manual, page-by-page search of their entire contents looking for potentially eligible studies) 
0 1 1 0 0 0   
 
Satisfies 4-5? score 4       3?=score 3       2?=score 2      1 or 0?=score 1 2 4 4 3 4 3  20 
          
4. Was the status of publication (i.e. grey literature) used as an inclusion criterion?         
(Grey literature is literature produced at all levels of government, academia, business and industry in print and 
electronic formats, but is not controlled by commercial publishers. Examples can be but not limited to 
dissertations, conference proceedings.) 
        
 (A) The authors should state that they searched for reports regardless of their publication type. 0 0 1 0 0 0   
 
(B) The authors should state whether or not they excluded any reports (from the systematic review), based on 
their publication status, language etc. 1 1 1 0 1 1   
 (C) “Non-English papers were translated” or readers sufficiently trained in foreign language 0 1 1 0 0 0   
 (D) No language restriction or recognition of non-English articles 0 1 1 0 0 0   
 
Satisfies 3-4? score 4       2?=score 3       1?=score 2      0?=score 1 2 4 4 1 2 2  15 
          
5. Was a list of studies (included and excluded) provided?         
 (A) Table/list/or figure of included studies, a reference list does not suffice. 1 1 1 0 1 1   
 
(B) Table/list/figure of excluded studies* either in the article or in a supplemental source (i.e. online). (Excluded 
studies refers to those studies seriously considered on the basis of title and/or abstract, but rejected after 
reading the body of the text) [*It is worth to have a brief overview of the excluded studies, since they do 
present relevant clinical information.] 0 0 1 0 0 0   




(D) Reader is able to retrace the included and the excluded studies anywhere in the article bibliography, 
reference, or supplemental source. 0 0 0 0 0 0   
 
Satisfies 4? score 4        3?=score 3       2?=score 2      1 or 0?=score 1 1 2 3 1 1 1  9 
          
6. Were the characteristics of the included studies provided?         
 
(A) In an aggregated form such as a table, data from the original studies should be provided on the participants, 
interventions AND outcomes. 1 1 1 0 1 1   
 
(B) Provide the ranges of relevant characteristics in the studies analyzed (e.g. age, race, sex, relevant 
socioeconomic data, disease status, duration, severity, or other diseases should be reported.) 
1 1 0 0 1 1   
 
(C) The information provided appears to be complete and accurate (i.e. there is a tolerable range of subjectivity 
here. Is the reader left wondering? If so, state the needed information and the reasoning). 
1 1 1 0 1 0   
 
Satisfies 3? score 4       2?=score 3       1?=score 2      0?=score 1 4 4 3 1 4 3  19 
 
 
         
7. Was the scientific quality of the included studies assessed and documented?         
 
(A) ‘A priori’ methods of assessment should be provided (e.g., for effectiveness studies if the author(s) chose to 
include only randomized, double-blind, placebo controlled studies, or allocation concealment as inclusion 
criteria); for other types of studies alternative items will be relevant. 
1 1 1 0 1 1   
 (B) The scientific quality of the included studies appears to be meaningful.  1 1 1 0 1 1   
 (C) Discussion/recognition/awareness of level of evidence 1 1 1 0 1 1   
 
(D) Quality of evidence should be rated/ranked based on characterized instruments. (Characterized instrument 
is a created instrument that ranks the level of evidence, e.g. GRADE [Grading of Recommendations Assessment, 
Development and Evaluation.]) 1 1 1 0 1 1   
 
Satisfies 4? score 4        3?=score 3       2?=score 2      1 or 0?=score 1 4 4 4 1 4 4  21 
          
 
8. Was the scientific quality of the included studies used appropriately in formulating conclusions? 
        
 
(A) The results of the methodological rigor and scientific quality should be considered in the analysis and the 
conclusions of the review 1 1 1 0 1 0   
 
(B) The results of the methodological rigor and scientific quality are explicitly stated in formulating 
recommendations. 1 1 1 0 1 0   
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 (C) To have conclusions integrated/drives towards a clinical consensus statement  0 1 0 0 0 0   
 (D) This clinical consensus statement drives toward revision or confirmation of clinical practice guidelines 0 1 0 0 0 0   
 
Satisfies 4? score 4        3?=score 3       2?=score 2      1 or 0?=score 1 2 4 2 1 2 1  12 
 
 
         
9. Were the methods used to combine the findings of studies appropriate?         
 (A) Statement of criteria that were used to decide that the studies analyzed were similar enough to be pooled?  1 1 1 0 0 0   
 
(B) For the pooled results, a test should be done to ensure the studies were combinable, to assess their 
homogeneity (i.e. Chi-squared test for homogeneity, I􀀁). 0 1 1 0 0 0   
 
(C) Is there a recognition of heterogeneity or lack of thereof 1 1 1 0 1 0   
 
(D) If heterogeneity exists a “random effects model” should be used and/or the rationale (i.e. clinical 
appropriateness) of combining should be taken into consideration (i.e. is it sensible to combine?), or stated 
explicitly 1 1 1 0 0 0   
 (E) If homogeneity exists, author should state a rationale or a statistical test 0 0 1 0 0 0   
 
Satisfies 4? score 4        3?=score 3       2?=score 2      1 or 0?=score 1 3 4 4 1 1 1  14 
 
 
         
10. Was the likelihood of publication bias (a.k.a. “file drawer” effect) assessed?         
 
(A) Recognition of publication bias or file-drawer effect 1 1 1 0 0 1   
 
(B) An assessment of publication bias should include graphical aids (e.g., funnel plot, other available tests) 
1 1 1 0 0 0   
 
(C) Statistical tests (e.g., Egger regression test). 0 0 1 0 0 0   
 
Satisfies 3? score 4       2?=score 3       1?=score 2      0?=score 1 3 3 4 1 1 2  14 
          
 
11. Was the conflict of interest stated?         
 (A) Statement of sources of support 0 0 1 0 0 1   
 (B) No conflict of interest. This is subjective and may require some deduction or searching. 0 1 1 0 1 1   
 (C) An awareness/statement of support or conflict of interest in the primary inclusion studies 1 1 1 0 0 0   
 
Satisfies 3? score 4       2?=score 3       1?=score 2      0?=score 1 2 3 4 1 2 3  15 
 *In cases where part of the question is yes and part is no, we have rated it a 1.          
 Total possible score = 44         Total possible score for each section = 24         
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 Quality rating (low = < 30; high = ≥ 30) 31 40 40 15 26 27   
  H H H L L L   


























































Supplemental file #3 - PRISMA 2009 CHECKLIST  
Section/topic  # Checklist item  
Reported 
on page #  
TITLE   
Title  1 Identify the report as a systematic review, meta-analysis, or both.  1 
ABSTRACT   
Structured summary  2 Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, 
participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and 
implications of key findings; systematic review registration number.  
1 
INTRODUCTION   
Rationale  3 Describe the rationale for the review in the context of what is already known.  2 
Objectives  4 Provide an explicit statement of questions being addressed with reference to participants, interventions, 
comparisons, outcomes, and study design (PICOS).  
2 
METHODS   
Protocol and registration  5 Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide 
registration information including registration number.  
Not 
registered 
Eligibility criteria  6 Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, 
language, publication status) used as criteria for eligibility, giving rationale.  
3 
Information sources  7 Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify 
additional studies) in the search and date last searched.  
4 




Study selection  9 State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, 
included in the meta-analysis).  
4-5 
Data collection process  10 Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes 
for obtaining and confirming data from investigators.  
5-6 
Data items  11 List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and 
simplifications made.  
3-4 
Risk of bias in individual 
studies  
12 Describe methods used for assessing risk of bias of individual studies (including specification of whether this was 





Section/topic  # Checklist item  
Reported 
on page #  
Risk of bias across studies  15 Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective 
reporting within studies).  
5-6 
Additional analyses  16 Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating 
which were pre-specified.  
n/a 
RESULTS   
Study selection  17 Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at 
each stage, ideally with a flow diagram.  
4 
Study characteristics  18 For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and 
provide the citations.  
Table 2 
Risk of bias within studies  19 Present data on risk of bias of each study and, if available, any outcome level assessment (see item 12).  Add. file #2 
Quality 
Assessment 
Results of individual studies  20 For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each 
intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.  
Tables 2 & 
3 
Synthesis of results  21 Present results of each meta-analysis done, including confidence intervals and measures of consistency.  9, 10 & 11 
Risk of bias across studies  22 Present results of any assessment of risk of bias across studies (see Item 15).  5-6 
Additional analysis  23 Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item 16]).  n/a 
DISCUSSION   
Summary of evidence  24 Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to 
key groups (e.g., healthcare providers, users, and policy makers).  
11 & 12 
Limitations  25 Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of 
identified research, reporting bias).  
12 & 13 
Conclusions  26 Provide a general interpretation of the results in the context of other evidence, and implications for future research.  13 
FUNDING   
Summary measures  13 State the principal summary measures (e.g., risk ratio, difference in means).  6-7 
Synthesis of results  14 Describe the methods of handling data and combining results of studies, if done, including measures of consistency 




Funding  27 Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the 
systematic review.  
13 
 
From:  Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group (2009). Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement. PLoS Med 6(6): e1000097. 
doi:10.1371/journal.pmed1000097  










Supplemental file #4 – Further Characteristics of Included Systematic Reviews 
(Author, year) 
country  
Participants, Patient population, age & 
gender (mean, median or range)  
Risk of bias assessment; evaluation of 
quality 
Follow-ups and attrition/drop-out rates Authors' conclusions 
(Ciere et al., 2012) 
UK 
Adults with heart failure, mostly mild/ 
moderately impaired; Some w/ none or 
severe impairment; 888 with heart 
failure; Sample sizes 18 to 284 (median 
age 74, mean age 61–78); 3 studies 
focused on older heart failure patients; 1 
on coronary artery bypass graft surgery 
patients.  
Overall study quality was poor; one 
study rated moderate. Common 
weaknesses: reporting of statistical 
power and blinding of assessors. 
Approximately half rated poor for 
reporting potential selection bias, 
independence of data collection, 
attrition, intervention integrity and 
appropriateness of statistical analyses; 
Study authors insufficiently guarded 
against forms of experimenter bias 
including confirmation bias. 
Between 2 to 12 mos after start of trial; 5 
studies delayed follow-up for some/all 
outcome measures; Five RCTs analyzed 
group differences in self-efficacy at 
follow-up. 1 found TH improved self-
efficacy over CG; 2 found no group 
differences; 2 comparing multiple arms 
found some group differences but none 
between IG and CG.  
Individual studies were considered to have contributed confirmatory 
evidence if they reported findings that were statistically significant, 
internally consistent and in the direction hypothesized in our model. 
These studies provide insufficient evidence to robustly support or 
disprove any of the hypothesized relationships in the proposed 
model. Research on heart failure patients has failed to adequately 
examine cognitive and behavioral mediators that may account for 
the reported effects of TH.  
(Guo & Albright, 
2018) 
USA 
4137 Older adults w/ heart failure, 
hypertension, diabetes, pain, COPD, lung 
disease, rheumatoid arthritis and other 
chronic conditions.  Average age 55+ 
years. 
Selection bias, performance bias, 
detection bias, attrition bias, and 
reporting bias were assessed for low, 
unclear or high risk. Attrition bias of 
the 31 studies was rated as LR (20), UR 
(7) and HR (4). The quality was 
evaluated with Cochran’s quality of 
evidence guideline. 
About a third of studies reported follow-
ups which were completed anywhere 
from 3 months (Gellis (2012) chronic 
heart or respiratory failure - 3 mos for 
health condition, 12 mos for health care 
utilization) to 12 months (Pecina (2013) 
chronic conditions; De Lusignan (2001) 
heart failure). Drop-out rates were not 
reported.  
TH technologies are generally effective (some reporting ineffective) 
on SM for older adults with a wide range of LTCs, hence their use is 
advisable; Consider racial diversity and culture-related acceptance 
differences; Promote consistent interaction between patients and 
HCPs; Use of LDCs is efficient to assist routine communication with 
HCPs who can mentor and assist patients’ self-care effectively; 
Suggest future experimental design studies to examine HCPs 
performance on TH effectiveness.  
(Ma et al., 2019) 
Hong Kong 
3998 with Hypertension, mean age 50-
68; Eight studies involved male 
participants at above 50%. Patients 
w/clinical diagnosis of HT, w/or w/o 
adequate BP control, w/inadequate BP 
control, or w/uncontrolled Hypertension 
w/kidney disease, obesity & type 2 
diabetes. 
9 reported random sequence 
generation details; 6 reported 
allocation concealment details, lack of 
which could increase the risk of 
selection bias. 10 unclearly reported 
blinding of outcome assessors, 
increasing concern of detection bias. 
11 reported baseline similarity of 2 
groups. Majority of studies used 
intention-to-treat analysis, reliable 
measurements and appropriate 
statistical analysis. 
4 studies completed follow-up. Margolis 
(2013) conducted a 6-month post-
intervention follow-up. Magid (2013) 
instructed participants to follow up with 
their primary care physician.  The drop-
out rate of the included studies ranged 
from 0.67% to 20.67% which influenced 
the attrition bias. Total drop-outs 358; 1 
study didn’t report.  
eHealth interventions are conducive to hypertension control; could 
be a potential mean to promote hypertension self-care; significantly 
affected the reduction of systolic and diastolic blood pressure; 
significantly decreased the proportion of patients within adequate 
blood pressure control and their body weight and could be a 
promising alternative in the management of hypertension. Authors 
call for rigorous experimental design on hypertension self-care to 
provide a robust evidence for a wide population and to address the 
increasing health care needs. Implications for research 
recommended long-term follow-ups.  
39 
 
(McCabe et al., 
2017) 
UK 
557 participants with COPD  Avg age 64 
years; 64.9% men 
An overall low quality was reported. 
Included studies rated unclear or low 
risk on selection bias;  high on risk of 
detection bias; risk of reporting bias 
was low; selection and attrition bias 
was high or unclear. Authors concluded 
that all 3 studies were of high risk of 
bias. 
All three studies had incomplete outcome 
data. Intervention group and control 
group rates of 25% and 17%, 6% and 
3.5%, and 22% and 0% were attributed to 
failure to complete surveys or follow-up 
measurements, death, exclusion from 
analysis with reason not given, 
participation burden and technical failure.  
Interventions aimed at facilitating, supporting and sustaining SM in 
people with COPD and delivered via smart technology significantly 
improved HRQoL and levels of activity up to 6 mos compared with 
interventions given through face-to-face/digital and/or written 
support; No firm conclusions drawn; Evidence is of poor quality and 
insufficient for advising on health benefits of using smart technology 
for supporting, encouraging, and sustaining SM of COPD. Further 
research should focus on outcomes relevant to different stages of 
COPD; provide clear information on how SM is assessed; include 
longitudinal measures that allow comment on behavioral change.  
(Tyack & Camic, 
2017) 
UK 
312 people w/ Dementia Mean ages 74.3 
- 84.5, ages reported in half of the 
studies; People with dementia (any type) 
and/or their carers (informal carers, care 
staff, art therapists or facilitators). Total 
PWD/carers is unclear as 
participants/cohorts in study phases may 
overlap. Sample sizes 2-40 (median = 12) 
Variable quality results were reported 
ranging from 25% to 100%. 
Generally, neither follow-ups not drop-
outs were reported in Table 3. Study 
Characteristics. One study did mention 
interviews with people with dementia 
“after 2 weeks about their experiences 
with PG” device, but no results were 
given.  
Touchscreen-based interventions can confer a wide range of 
benefits to the well-being of PWD in relation to their mood and 
mental health and their sense of mastery. Important procedural 
aspects besides support included involving potential users in the 
development process, an errorless learning method for training, 
requiring motor-action during training and the ability to use the 
intervention with little preparation.  Introduction of interventions 
earlier in the progress of users’ dementia facilitated uptake. 
Hardware considerations included ergonomics, screen quality, 
consistency and a conspicuous location.  
Acronyms: BP – Blood pressure; CG - control group; HCP - health care provider; HHMS - home-health monitoring system; HRQoL -  health-related quality of life; HT - Hypertension;  IG - intervention group; LDC - long-distance 
communication technology; MTP - telehealth program applying multiple telehealth technologies; PA - Physical activity; PRISMS - Practical Reviews in Self-Management Support; PWD - People with dementia; RCT - randomized 
controlled trial;  SM - Self-management; TET - tele-education technology;       TH - Telehealth; WBT - web-based technology 
 
 
